Related Experiment Video
Updated: May 5, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin
Yu Wang1, Hafid Ait-Oufella, Olivier Herbin
1INSERM U970, Paris Cardiovascular Research Center, Université Paris-Descartes and Assistance Publique-Hôpitaux de Paris, Paris, France.
Abstract:
Complicated abdominal aortic aneurysm (AAA) is a major cause of mortality in elderly men. Ang II-dependent TGF-beta activity promotes aortic aneurysm progression in experimental Marfan syndrome. However, the role of TGF-beta in experimental models of AAA has not been comprehensively assessed. Here, we show that systemic neutralization of TGF-beta activity breaks the resistance of normocholesterolemic C57BL/6 mice to Ang II-induced AAA formation and markedly increases their susceptibility to the disease. These aneurysms displayed a large spectrum of complications on echography, including fissuration, double channel formation, and rupture, leading to death from aneurysm complications. The disease was refractory to inhibition of IFN-gamma, IL-4, IL-6, or TNF-alpha signaling. Genetic deletion of T and B cells or inhibition of the CX3CR1 pathway resulted in partial protection. Interestingly, neutralization of TGF-beta activity enhanced monocyte invasiveness, and monocyte depletion markedly inhibited aneurysm progression and complications. Finally, TGF-beta neutralization increased MMP-12 activity, and MMP-12 deficiency prevented aneurysm rupture. These results clearly identify a critical role for TGF-beta in the taming of the innate immune response and the preservation of vessel integrity in C57BL/6 mice, which contrasts with its reported pathogenic role in Marfan syndrome.
Insights
Transforming growth factor-beta (TGF-β) neutralization increases susceptibility to abdominal aortic aneurysm (AAA) in mice. This study reveals TGF-β’s protective role in innate immunity and vessel integrity, contrasting its role in Marfan syndrome.
Area of Science:
- Cardiovascular Biology
- Immunology
- Vascular Biology
Background:
- Abdominal aortic aneurysm (AAA) poses a significant mortality risk, particularly in elderly men.
- Angiotensin II (Ang II)-dependent TGF-β activity is implicated in aortic aneurysm progression in Marfan syndrome.
- The specific role of TGF-β in experimental AAA models remains incompletely understood.
Purpose of the Study:
- To comprehensively assess the role of TGF-β in experimental models of Ang II-induced AAA.
- To investigate the impact of TGF-β neutralization on AAA formation and complications in normocholesterolemic mice.
Main Methods:
- Systemic neutralization of TGF-β activity in normocholesterolemic C57BL/6 mice subjected to Ang II infusion.
- Echographic assessment of aneurysm complications (fissuration, double channel formation, rupture).
- Evaluation of immune cell involvement (T cells, B cells, monocytes) and specific molecular pathways (IFN-γ, IL-4, IL-6, TNF-α, CX3CR1, MMP-12).
Main Results:
- TGF-β neutralization significantly increased susceptibility to Ang II-induced AAA formation and complications, including rupture and death.
- Aneurysm development was refractory to inhibition of IFN-γ, IL-4, IL-6, or TNF-α signaling.
- Monocyte depletion and MMP-12 deficiency markedly inhibited AAA progression and rupture, respectively, while TGF-β neutralization enhanced monocyte invasiveness and MMP-12 activity.
Conclusions:
- TGF-β plays a critical role in modulating the innate immune response and maintaining vascular integrity in C57BL/6 mice, protecting against AAA.
- This protective role contrasts with the previously reported pathogenic role of TGF-β in Marfan syndrome-associated AAA.
- Targeting TGF-β may exacerbate AAA, highlighting its complex involvement in vascular disease pathogenesis.
More Related Videos
06:08Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
Published on: March 8, 2019
10:09Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound
Published on: August 4, 2022